21 employees
Waterstone Pharmaceuticals is engaged in the development of various drugs for the treatment of liver and gastrointestinal diseases.
2008
$3.4M
from 2 investors over 2 rounds
Waterstone Pharmaceuticals, Inc. raised $3.4M on August 21, 2012
Investors: ACORN CAMPUS, L.L.C. and -